NCT02488291

Completed

Effect of Sufentanil and Ropivacaine

Fudan University Source

Compare

Other study identifiers

Sponsor study identifier

IPMCH

Study Type

interventional

Actual enrollment (reported)

120

Locations

0 countries

Sites

N/A

Timeline

Study Start

April 2014

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

June 2015

Actual (reported)

Study Completion

June 2015

Actual (reported)

Brief Summary

The investigators study the efficacy of epidural sufentanil/ropivacaine for analgesia labor in primiparas so as to decrease perinatal complications of analgesia labor.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 120 participants
Study completion date: June 2015
Actual (reported)
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
April 2014
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
June 2015
Actual (reported)
Study Completion
June 2015
Actual (reported)
First Submitted
June 20, 2015
Actual (reported)
First Posted
July 2, 2015
Actual (reported)

Last Updated: August 12, 2020
Status Verified: August 2020
Last Update Submitted: August 10, 2020

Conditions

Anesthesia Complications

Keywords

EpiduralAnalgesia laborPerinatalanesthesia

Outcome Measures

Primary Outcomes (1)

VAS(visual analog pain score)
comparison with two groups
1 year

Study Arms (2)

0.5 sufentanil

EXPERIMENTAL

0.5µg/ml sufentanil, 0.1% ropivacaine for 6ml/h

Drug: 0.5µg/ml sufentanilDrug: 0.1% ropivacaine

0.25 sufentanil

EXPERIMENTAL

0.25µg/ml sufentanil, 0.1% ropivacaine for 6ml/h

Drug: 0.25 sufentanilDrug: 0.1% ropivacaine

Interventions

0.25 sufentanilDrug

with different dosage

Also known as: opiods

0.25 sufentanil

0.5µg/ml sufentanilDrug

0.5µg/ml sufentanil

Also known as: opiods

0.5 sufentanil

Eligibility Criteria

Age25 Years - 35 Years

Sexfemale

Healthy VolunteersNo

Age GroupsAdult (18-64)

You may qualify if:

Patients had regular prenatal examinations at the outpatient clinic;
They were between 25 to 35 years of age)

Sponsors & Collaborators

Shanghai Jiao Tong University School of Medicine
Othercollaborator
Fudan University
Otherlead

MeSH Terms

Interventions

SufentanilRopivacaineAnesthetics, Local

Intervention Hierarchy (Ancestors)

FentanylPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesAnestheticsCentral Nervous System DepressantsPhysiological Effects of Drugs

Study Officials

Zeyong Yang, M.D.
Fudan University, Shanghai Jiaotong University
PRINCIPAL INVESTIGATOR

Enrollment

120 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: SINGLE
Who Masked: INVESTIGATOR
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Hospital

Study Record Dates

First Submitted

June 20, 2015

First Posted

July 2, 2015

Study Start

April 2014

Date type not reported

This date has not been verified as actual or estimated.

NCT04317235

Ultrasound-guided Interscalene Block:3mL Ropi Provide Similar Analgesia to 5mL and Less Diaphragmatic Paralysis

Not ApplicableCompleted

NCT07894770

The 90% Effective Initial Volume for Labor Analgesia Under Double Dural Puncture Epidural Technique

Not ApplicableNot Yet Recruiting

NCT02893423

Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia

Not ApplicableTerminated

NCT02512471

The Minimum Effective Volume of Ropivacaine in Ultrasound-guided Supraclavicular Block

Not ApplicableCompleted

NCT02478372

Patient Controlled Epidural Analgesia Versus Local Infiltration Analgesia Following Knee Arthroplasty

Not ApplicableCompleted

NCT02033603

Adductor Canal Versus Femoral Nerve Block for Analgesia Post Total Knee Arthroscopy

Not ApplicableUnknown

0.1% ropivacaineDrug

0.1% ropivacaine

Also known as: Local Anesthetics

0.25 sufentanil0.5 sufentanil

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

They had a gestational age ≥37 weeks and \< 42 weeks;

They had an estimated fetal weight ≥ 2,500 g and \< 4,200 g.

You may not qualify if:

a history of spinal surgery,
platelet count \<100×109 /L ,
coagulation disorder,
sensorimotor disorder of lower extremity,
leg pain,
puncture point infection,
heart disease history,
pulmonary disease,
liver and renal function disorder and
a history of neuropsychiatry drugs.

Contact the study team to confirm eligibility.

Pharmacologic Actions

Chemical Actions and Uses

Sensory System Agents

Peripheral Nervous System Agents

Central Nervous System Agents

Therapeutic Uses

Primary Completion

June 2015

Actual (reported)

Study Completion

June 2015

Actual (reported)

Last Updated

August 12, 2020

Record last verified: 2020-08

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT02488291
Data provider: ClinicalTrials.gov
Source updated: 2020-08-12
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:33:31 UTC

Documents

Statistical Analysis Plan
SAP2016-06-30

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

0.5 sufentanil

0.25 sufentanil

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Documents